14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ADMP ranks #18000 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Adamis Pharmaceuticals Corporation Stock Forecast NASDAQ:ADMP

$0.61 (0.84%)

Volume: 1M

Closed: Jan 19, 2022

Hollow Logo Score: -5.861

Adamis Pharmaceuticals Corporation Stock Forecast

$0.61 (0.84%)

Volume: 1M

Closed: Jan 19, 2022

Score Hollow Logo -5.861

Adamis Pharmaceuticals Corporation Company Profile

11682 El Camino Real

San Diego CA 92130



Adamis Pharmaceuticals Corporation


Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, engages in developing and commercializing products in the therapeutic areas of allergy and respiratory disease. Its specialty pharmaceutical product candidates include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-2000 for the treatment of bronchospasms. The company also has various biotechnology product candidates and technologies, including therapeutic vaccine and cancer product candidates that comprise TeloB-VAX (vaccine), APC-100, APC-200, and APC-300, which are under development for the treatment of prostate cancer. In addition, it operates a 503B drug outsourcing facility that provides prescription medications to patients, physician clinics, hospitals, and surgery centers in the United States. The company is headquartered in San Diego, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE